Back to SYRE
TCG Crossover Management, LLC → SYRE
TCG Crossover Management, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$169.2M
Q3 2026
Peak value
$169.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $62.3M |
| Q1 2026 | $95.9M |
| Q2 2026 | $168.7M |
| Q3 2026 | $169.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $169.2M | 1.90M | — | — |
| Q2 2026 | $168.7M | 1.90M | — | — |
| Q1 2026 | $95.9M | 1.90M | — | — |
| Q4 2025 | $62.3M | 1.90M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC